retatrutide glp-1 gip glucagon receptor agonist Medscape | The investigational triple GLP-1/GIP/glucagon produced significant weight loss and A1c reduction in people retatrutide phase 3 2025 triple
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

























